Association of N-Terminal Pro-Brain Natriuretic Peptide with Cognitive Function and Depression in Elderly People with Type 2 Diabetes

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Feinkohl, Insa ^a   Sattar, Naveed ^b   Welsh, Paul ^b   Reynolds, Rebecca M ^c   Deary, Ian J ^a,d   Strachan, Mark W J ^e   Price, Jackie F ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIDIABETIC AGENT; INSULIN;

ADULT; AGE; AGED; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE BLOOD LEVEL; ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; COVARIANCE; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LINGUISTICS; MAJOR CLINICAL STUDY; MALE; MENTAL CAPACITY; MORBIDITY; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SEX; STANDARDIZATION; STATISTICAL SIGNIFICANCE;

AGED; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; COGNITION; CROSS-SECTIONAL STUDIES; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS;

EID: 84866009662     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044569     Document Type: Article

References (50)

1. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol: 64-74.
2. Cukierman T, Gerstein HC, Williamson KD, (2005) Cognitive decline and dementia in diabetes- systematic overview of prospective observational studies. Diabetologia 48: 2460-2469.
3. Bourdel-Marchasson I, Lapre E, Laksir H, Puget E, (2010) Insulin resistance, diabetes and cognitive function: consequences for preventative strategies. Diabetes Metab 26: 173-181.
4. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K, (2006) The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 23: 1165-1173.
5. Anderson RJ, Freeland KE, Clouse RE, Lustman P, (2001) The prevalence of comorbid depression in adults with diabetes. Diabetes Care 24: 1069-1078.
6. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, et al. (2001) Risk factors for congestive heart failure in US men and women. Arch Intern Med 161: 996-1002.
7. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB, (2004) The incidence of congestive heart failure in type 2 diabetes. Diabetes Care 27: 1879-1884.
8. Doust JA, Glasziou PP, Pietrzak E, Dobson AJ, (2004) A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 164: 1978-1984.
9. Andersen NH, Poulsen SH, Knudsen ST, Heickendorff L, Mogensen CE, (2005) NT-proBNP in normoalbuminuric patients with type 2 diabetes mellitus. Diabet Med 22: 188-195.
10. Magnusson M, Melander O, Israelsson B, Grubb A, Groop L, et al. (2004) Elevated plasma levels of NT-proBNP in patients with type 2 diabetes without overt cardiovascular disease. Diabetes Care 27: 1929-1935.
11. Castleberry C, Lo S, Tillman K, Stendahl G, Ahn J, et al. (2010) NT-proBNP versus BNP and their correlation with cardiac function in pediatric transplant of heart failure patients. J Am Coll Cardiol 55: A43.E410.
12. Daniels LB, Chen W-C, Kritz-Silverstein D, Laughlin GA, Maisel AS, et al. (2009) Elevated NT-proBNP levels are associated with poor cognitive function in apparently healthy older adults: results from the Rancho Bernado Study. Circulation 120: S542.
13. Mauro F, Rosso GL, Peano M, Agostini M, Aspromonte N, et al. (2007) Correlation between cognitive impairment and prognostic parameters in patients with congestive heart failure. Arch Med Res 38: 234-239.
14. Gunstad J, Poppas A, Smeal S, Paul RH, Tate DF, et al. (2006) Relation of brain natriuretic peptide levels to cognitive dysfunction in adults >55 years of age with cardiovascular disease. Am J Cardiol 98: 538-540.
15. Kondziella D, Goethlin M, Fu M, Zetterberg H, Wallin A, (2009) B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia. Neuroreport 20: 825-827.
16. Suwa M, Ito T, (2009) Correlation between cognitive impairment and left ventricular diastolic dysfunction in patients with cardiovascular diseases. Int J Cardiol 136: 351-354.
17. Naito J, Naka Y, Watanabe H, (2009) Clinical impression of brain natriuretic peptide levels in demented patients without cardiovascular disease. Geriatr Gerontol Int 9: 242-245.
18. Kerola T, Nieminen T, Hartikainen S, Sulkava R, Vuolteenaho O, et al. (2010) B-type natriuretic peptide as a predictor of declining cognitive function and dementia- a cohort study of an elderly general population with a 5-year follow-up. Ann Med 42: 207-215.
19. Politi P, Minoretti P, Piaggi N, Brondino N, Emanuele E, (2007) Elevated plasma N-terminal proBNP levels in unmedicated patients with major depressive disorder. Neurosci Lett 417: 322-325.
20. Bunevicius R, Varoneckas G, Prange AJJ, Hinderliter AL, Fintauskiene V, et al. (2006) Depression and thyroid axis function in coronary artery disease: impact of cardiac imapirment and gender. Clin Cardiol 29: 170-174.
21. Jankowska EA, Drohomirecka A, Ponikowska B, Witkowska A, Lopuszanska M, et al. (2010) Deficiencies in circulating testosterone and dehydroepiandrosterone sulphate and depression in men with systolic chronic heart failure. Eur J Heart Fail 12: 966-973.
22. van den Broek KC, deFilippi CR, Christenson RH, Seliger SL, Gottdiener JS, et al. (2011) Predictive value of depressive symptoms and b-type natriuretic peptide for new-onset heart failure and mortality. Am J Cardiol 107: 723.
23. Almeida OP, Tamai S, (2011) Congestive heart failure and cognitive functioning amongst older adults. Arq Neuropsiquiatr 59: 324-329.
24. Zuccala G, Cattel C, Manes-Gravina E, Di Niro MG, Cocchi A, et al. (1997) Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry 63: 509-512.
25. van Melle JP, de Jonge P, Ormel J, Crijns HJ, van Veldhuisen DJ, et al. (2005) Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT. Eur Heart J 26: 2650-2656.
26. Bankier B, Barajas J, Martinez-Rumayor A, Januzzi JL, (2008) Association between c-reactive protein and generalised anxiety disorder in stable coronary heart disease patients. Eur Heart J 29: 2212-2217.
27. Bankier B, Barajas J, Martinez-Rumayor A, Januzzi JL, (2009) Association between major depressive disorder and c-reactive protein levels in stable coronary heart disease patients. J Psychosom Res 66: 189-194.
28. Bekelman DB, Havranek EP, Becker DM, Kutner JS, Peterson PN, et al. (2007) Symptoms, depression and quality of life in patients with heart failure. J Card Fail 13: 643-648.
29. Mueller-Tasch T, Peters-Klimm F, Schellberg D, Holzapfel N, Juenger J, et al. (2007) Depression is a major determinant of quality of life in patients with chronic systolic heart failure in general practice. J Card Fail 13: 818-824.
30. Vaes B, de Ruijter W, Degryse J, Westendorp RGJ, Gussekloo J, (2009) Clinical relevance of a raised plasma N-terminal pro-brain natriuretic peptide level in a population-based cohort of Nonagenarians. J Am Geriatr Soc 57: 823-829.
31. Nilsson K, Gustafson L, Hultberg B, (2010) The clinical use of N-terminal-pro brain natriuretic peptide in elderly patients with mental illness. Clin Biochem 43: 1282-1286.
32. Price JF, Reynolds RM, Mitchell RJ, Williamson RM, Fowkes FGR, et al. (2008) The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endocr Disord 8: 18-27.
33. Hayashi C, Ogawa O, Kubo S, Mitsuhashi N, Onuma T, et al. (2004) Ankle brachial pressure index and carotid intima-media thickness as atherosclerosis markers in Japanese diabetics. Diabetes Res Clin Pract 66: 269-275.
34. Curb JD, Masaki K, Rodriguez BL, Abbott RD, Burchfiel CM, et al. (1996) Peripheral artery disease and cardiovascular risk factors in the elderly- the Honolulu Heart Program. Arterioscler Thromb Vasc Biol 16: 1495-1500.
35. Marioni RE, Strachan MWJ, Reynolds RM, Lowe GDO, Mitchell RJ, et al. (2010) Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes. Diabetes 59: 710-713.
36. Deary IJ, Whalley LJ, Crawford JR, (2004) An 'instantaneous' estimate of a lifetime's cognitive change. Intelligence 32: 113-119.
37. Crawford JR, Dearyt IJ, Starr J, Whalley LJ, (2001) The NART as an index of prior intellectual functioning: a retrospective validity study covering a 66-year interval. Psychol Med 31: 451-458.
38. Folstein MF, Folstein SE, McHugh PR, (1975) 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
39. Zigmond AS, Snaith RP, (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67: 361-370.
40. Olsson I, Mykletun A, Dahl AA, (2005) The hospital anxiety and depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 5: 46.
41. Bjelland I, Dahl AA, Haug TT, Neckelmann D, (2002) The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res 52: 69-77.
42. Spearman C, (1904) 'General intelligence', objectively determined and measured. Am J Psychol 15: 201-292.
43. Luciano M, Marioni RE, Gow AJ, Starr J, Deary IJ, (2009) Reverse causation in the association between c-reactive protein and fibrinogen levels and cognitive ability in an aging sample. Psychosom Med 71: 404-409.
44. Deary IJ, Der G, (2005) Reaction time explains IQ's association with death. Psychol Sci 16: 64-69.
45. Tombaugh TN, McIntyre NJ, (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40: 922-935.
46. Reijmer YD, van den Berg I, Ruis C, Kappelle LJ, Biessels GJ, (2010) Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 26: 507-519.
47. Carney RM, Freeland KE, Miller GE, Jaffe AS, (2002) Depression as a risk factor for cardiac mortality and morbidity. J Psychosom Res 53: 897-902.
48. Thomas SA, Chapa DW, Friedmann E, Durden C, Ross A, et al. (2008) Depression in patients with heart failure: prevalence, pathophysiological mechanisms and treatment. Crit Care Nurse 28: 40-55.
49. Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, et al. (2009) B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation 120: 2177-2187.
50. Wannamethee SG, Welsh P, Lowe GD, Gudnason V, Di Angelantonio E, et al. (2011) N-terminal pro-brain natriuretic peptide is a more useful predictor of cardiovascular disease risk than c-reactive protein in older men with and without pre-existing cardiovascular disease. J Am Coll Cardiol 58: 56-64.